Insiders trading at Enfusion
Over the last 3 years, insiders at Enfusion have traded over $144,301,080 worth of Enfusion stock and bought 2,523,188 units worth $42,894,196 . The most active insiders traders include Investment Management, Ltd...., Bradford Eftv Iv, L.P. Bern... és Tarek Lra Ventures, Llc Ham.... On average, Enfusion executives and independent directors trade stock every 22 days with the average trade being worth of $2,488,344. The most recent stock trade was executed by Valeria Gutowski on 18 June 2024, trading 1,258 units of ENFN stock currently worth $10,278.
What does Enfusion's logo look like?
Enfusion executives and stock owners
Enfusion executives and other stock owners filed with the SEC include:
-
Bronwen Bastone,
Chief People Officer -
Lorelei M. Skillman,
Chief Marketing Officer -
Brian Murphy,
Investor -
Daniel Groman,
MD & CTO -
Alan Polo,
Head of Account Management -
Michael Berry,
Chief Operating Officer -
Stephen P. Dorton,
Chief Financial Officer -
Stephen Malherbe,
Managing Partner -
Thomas Kim,
Chief Exec. Officer -
Tarek Hammoud,
Co-Founder & Exec. Chairman -
Steven M. Bachert,
Chief Revenue Officer -
Bradley Herring,
Chief Financial Officer -
Michael Spellacy,
Director -
Deirdre Somers,
Director -
Matthew Campobasso,
General Counsel -
Neal Pawar,
Chief Operating Officer -
Stephen Malherbe Investment...,
-
Lawrence E Leibowitz,
Director -
Bradford Eftv Iv, L.P. Bern...,
-
Oleg Movchan,
Director -
Oleg Csl Tech Holdings Llc ...,
Chief Executive Officer -
Investment Management, Ltd....,
10% owner -
Tarek Hammoud,
Director -
Strategic Partners V, L.P.I...,
-
Roy Luo,
Director -
Jan Hauser,
Director -
Kathleen De Rose,
Director -
Thomas Kim,
Chief Executive Officer -
Lorelei M. Skillman,
Chief Mrktg. & Comm. Officer -
Stephen M Dorton,
Chief Financial Officer -
Bronwen Bastone,
Chief People Officer -
Dan Groman,
Chief Technology Officer -
Tarek Lra Ventures, Llc Ham...,
-
Oleg Quiet Light Securities...,
Chief Executive Officer -
Valeria Gutowski,
Chief Accounting Officer